当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析 - 资产负债表

鲁抗医药

(600789)

  

流通市值:53.05亿  总市值:53.05亿
流通股本:8.96亿   总股本:8.96亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金798,462,181.64563,797,446.4614,103,269.77625,660,620.62
应收票据及应收账款801,646,450.87882,774,800.44734,788,433.32917,576,588.55
应收账款801,646,450.87882,774,800.44734,788,433.32917,576,588.55
应收款项融资544,404,914.77392,537,923.35262,512,359.24228,722,292.93
预付款项49,265,102.09124,152,669.2567,523,967.2682,766,393.24
其他应收款合计14,241,440.8826,692,487.1424,763,267.8517,792,523.52
存货1,405,980,579.441,453,198,667.21,484,702,139.41,503,632,882.92
其他流动资产32,603,104.2712,759,738.5512,744,756.1110,094,644.17
流动资产平衡项目0000
流动资产合计3,647,794,413.963,457,188,012.333,202,459,212.953,387,520,225.95
非流动资产:
长期应收款171,800,633.19169,800,068155,233,535.31145,686,877.57
长期股权投资77,869,472.9755,643,295.1757,451,402.4558,529,346.99
其他权益工具投资25,256,557.9126,605,040.8726,605,040.8730,405,860.42
投资性房地产54,328,474.4574,735,525.0263,664,269.7165,958,379.65
固定资产3,786,111,517.73,724,727,052.193,725,416,678.663,814,117,310.61
在建工程100,968,217.0160,460,919.34200,162,513.79222,962,108.42
使用权资产-1,659,878.12146,135.96365,339.97
无形资产724,043,285.62729,439,317.32608,504,221.46595,152,338.73
开发支出106,974,209.07136,509,799.04148,625,655.95152,026,646.54
长期待摊费用816,620.112,038,457.382,933,995.633,857,513.44
递延所得税资产31,021,266.2325,581,907.825,682,170.0427,763,455.73
其他非流动资产75,446,829.65144,096,222.33120,501,165.1744,599,755.21
非流动资产平衡项目0000
非流动资产合计5,154,637,083.915,151,297,482.585,134,926,7855,161,424,933.28
资产平衡项目0000
资产总计8,802,431,497.878,608,485,494.918,337,385,997.958,548,945,159.23
流动负债:
短期借款1,102,496,577.1965,177,333.391,006,926,476.931,115,766,500.06
应付票据及应付账款1,502,638,161.071,437,491,832.951,302,803,815.761,639,052,951.56
其中:应付票据562,575,999438,493,319285,598,000562,738,000
应付账款940,062,162.07998,998,513.951,017,205,815.761,076,314,951.56
预收款项16,651.37---
合同负债141,638,153.01121,780,402.23122,348,640.1164,299,344.21
应付职工薪酬20,567,460.0825,759,193.2822,854,845.7221,428,608.58
应交税费25,629,605.936,464,499.4732,059,005.529,526,601.46
其他应付款合计228,649,899.47302,328,986.64347,165,666.68300,356,865.26
应付股利1,680,905.491,680,905.491,680,905.491,680,905.49
一年内到期的非流动负债464,633,711.72161,691,025.96202,099,331.82207,585,734.69
其他流动负债31,060,478.9832,273,748.4449,150,12348,672,507.51
流动负债平衡项目0000
流动负债合计3,517,330,698.73,082,967,022.363,085,407,905.513,526,689,113.33
非流动负债:
长期借款1,308,926,0001,617,676,0001,372,276,0001,236,885,323.06
长期应付款123,857,705123,857,705123,857,705123,857,705
递延收益110,968,718.3599,340,151.84100,402,892.4792,332,067.14
非流动负债平衡项目0000
非流动负债合计1,543,752,423.351,840,873,856.841,596,536,597.471,453,075,095.2
负债平衡项目0000
负债合计5,061,083,122.054,923,840,879.24,681,944,502.984,979,764,208.53
所有者权益(或股东权益):
实收资本(或股本)896,037,392890,926,241889,032,299888,873,468
资本公积1,683,413,926.11,654,782,002.681,643,578,466.461,642,160,896.43
其他综合收益-14,743,442.09-13,394,959.13-13,394,959.13-9,594,139.58
专项储备451,317.081,708,763.63926,121.62752,843.43
盈余公积178,378,793.5164,430,657.99164,430,657.99164,430,657.99
未分配利润868,157,014.94828,484,815.51816,208,451.81730,518,718.41
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,611,695,001.533,526,937,521.683,500,781,037.753,417,142,444.68
少数股东权益129,653,374.29157,707,094.03154,660,457.22152,038,506.02
股东权益平衡项目0000
股东权益合计3,741,348,375.823,684,644,615.713,655,441,494.973,569,180,950.7
负债和股东权益合计8,802,431,497.878,608,485,494.918,337,385,997.958,548,945,159.23
公告日期2024-03-232023-10-262023-08-192023-04-19
审计意见(境内)标准无保留意见
TOP↑